Just took a gamble on these.The Company deals in the making and selling of biocides.It's looking to get into the treatment of MRSA among other things.It's awaiting regulatory approval for selling it's technology to the food & hygiene sector.
It has just started trading on the AIM.

Just been reading in the press, that a secret Government probe, has been looking into the impact of scrapping weekly rubbish collections.It's found that if it's made fortnightly (As it is in a third of councils in England & Wales).The risk of M.R.S.A. is far greater.I wonder if anyone at Byotrol is aware of this.
It could have an impact on the share price, if the company decided to supply councils with their products, to binmen & other employees.

Source:Daily Express 17th October

You're telling me that the UK is now sinking in rubbish? Don't ask me why I no longer live there . . . .

More good news that several multi-national companies have approached Byotrol about using there products.
Does anyone know who?

Please forgive me if this is a stupid question, as I'm just a private investor who bought into Byotrol on it's M.R.S.A. trials.

With the recent outbreak of bird flu wouldn't the use of byotrol technology be beneficial in helping to prevent bird flu outbreaks?

Bird flu is due to H5N1 that has mutated into a variety of strains with differing pathogenic profiles, some pathogenic to one species but not others, some pathogenic to multiple species. Each specific known genetic variation is traceable to a virus isolate of a specific case of infection. Through antigenic drift, H5N1 has mutated into dozens of highly pathogenic varieties divided into genetic clades which are known from specific isolates, but all currently belonging to genotype Z of avian influenza virus H5N1, now the dominant genotype.

So it is not so easy to eliminate bird flu. By the time Byotrol produces a treatment, it has mutated to another kind.

A favourable article in late June National Press has transformed this stock . . . bvut I still have reservations - it might be possible to pay "too much" before the profits start rolling.

AND - as far as I'm aware MRSA is still with us.

(Unless you are using "Dettol", that is)

They need to diversify and look into killing not just MRSA, but also Clostridium difficile.

Byotrol plc is engaged in the development, patenting and sale of products based on microbial technology. The Company operates in three segments: product sales, license fees and royalties. Its products can be used for a range of healthcare situations, from routine environmental cleaning to sanitization and disinfection. The Byotrol Assure range includes ready-for-use sprays and wipes for hard surfaces and instruments, liquids for hand cleaning and as dilute-to-use formulations for larger volume applications. The Agrisphere product range offers microbial control and helps protect against a number of hygiene issues that farmers face, including digital dermatitis, foot rot and salmonella. The Nanosphere product range offers microbial control against microbes, including Listeria, Legionella, E.coli, Salmonella, S aureus and campylo bacter. In February 2010, the Company acquired the business and certain assets of Byofresh Limited.

Every little helps...

Byotrol has been awarded a research grant by North West Development Agency. The NWDA grant, totalling 443,824, is to be paid over three years to develop, in particular, the range of applications in the consumer products division.

Byotrol secure agreement with Kimberley-Clark
StockMarketWire.com
Byotrol Consumer Products (BCP), Byotrol's 50% owned consumer products subsidiary, and Kimberly-Clark have agreed to enter into a full licensing agreement.

Details of the agreement are not being disclosed at this time and follows the successful completion of the initial joint development agreement with a Fortune 150 partner which Byotrol announced in January.

The new, seven-year contract is global in scope, with some exceptions including certain EU markets, and provides Kimberly-Clark exclusive intellectual property rights.

Kimberly-Clark's global brands sell in more than 175 countries. With names such as Kleenex, Scott, Huggies, Pull-Ups, Kotex and Depend, it holds the No. 1 or No. 2 share position in more than 80 countries.

Commenting on the commercial agreement, Ralph Kugler, Chairman at Byotrol, said: "This is a landmark agreement for Byotrol. It realises a central tenet of our strategy by partnering with a global consumer-focussed company.

"We are delighted to have worked so closely with a company as respected as Kimberly-Clark in arriving at this significant result, and we appreciate the commitment to Byotrol that Kimberly-Clark has shown from the earliest stage. The agreement also reflects the outstanding effort made by our partners at BCP."

Hello dreamcatcher: A good Manchester company (I should know, that’s where I'm from........Now in Kent)..........This company has struggled to get of the launch pad; I got severely burnt a couple of years back......I paid 21p, sold at 9p......oooch.
Hygiene antibacterial products. In my opinion, I feel they need large Hospital/laboratory type contracts.

I thought they would have moved when they got a contract with Rentokil........Shot up from 8p to 16p in a day........Then retreated to 6p and less.

Not sure when to re-enter.........Need to see momentum around the 8p mark, then I'm in!

Starting to climb G18 . Sorry to hear that. Lets hope you make your money back and more. :-)) Not invested here

Audio interview with Gary Millar, Chief Executive of Byotrol
Gary Millar, Chief Executive of Byotrol, discusses the interim results for the international hygiene business. The past six months saw many operational highlights including the licensing agreement with Kimberly Clark.

Click the link below to listen:

http://www.brrmedia.co.uk/event/106818/gary-millar-chief-executive

Gary Millar, Chief Executive of Byotrol, provides a commercial and trading update focusing on the significant announcement that Byotrol is to be adopted across Marks and Spencer stores. Byotrol sanitisers will now be used as thier in-store surface hygiene solution.
Click the link to listen to the interview;
http://www.brrmedia.co.uk/event/109637/gary-millar-chief-executive